Article
Evaluation of the anticancer activity of dipyridamole and Imatinib mesylate compounds against breast cancer cell line and related biochemical and genetic changes
Last updated: 26 Dec 2024
Article
Article
Article
Article
Article
Article
Article
Article
Article
Article